• Contact us
  • Email Whitelisting
  • Home 1
  • Privacy Policy
  • Terms & Conditions
  • Thank you
Wholesome Area - Beauty Secrets and Tips
No Result
View All Result
  • Health Care
  • Health News
  • Healthy Advices
  • Well Being
  • Health Care
  • Health News
  • Healthy Advices
  • Well Being
No Result
View All Result
Wholesome Area - Beauty Secrets and Tips
No Result
View All Result
Home Health Care

DOJ to ask Supreme Court to pause abortion pill restrictions from taking effect

by
April 13, 2023
in Health Care
0
DOJ to ask Supreme Court to pause abortion pill restrictions from taking effect
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Attorney General Merrick Garland on Thursday said the Department of Justice (DOJ) will ask the Supreme Court to pause a ruling that would roll back changes that make it easier to access mifepristone, the common abortion pill.

U.S. District Judge Matthew Kacsmaryk last week ruled that the Food and Drug Administration (FDA) violated federal standards when it first approved mifepristone 23 years ago, staying the agency’s initial approval of the pill.

Late Wednesday night, the 5th U.S. Circuit Court of Appeals ruled that mifepristone may remain on the market as the federal government’s appeal proceeds, but it meanwhile allowed portions of the Texas judge’s ruling to stand that would roll back a series of actions the FDA has taken since 2016 that eased access.

Those changes included allowing the mifepristone to be sent through the mail, lifting a requirement for three in-person visits, approving a generic and approving the drug’s use up to 10 weeks into a pregnancy, rather than seven weeks.

Garland will likely ask the Supreme Court to pause each of those remaining portions, which go into effect early Saturday morning, barring an intervention from the justices.

“The Justice Department strongly disagrees with the Fifth Circuit’s decision in Alliance for Hippocratic Medicine v. FDA to deny in part our request for a stay pending appeal,” Garland said in a statement on Thursday. “We will be seeking emergency relief from the Supreme Court to defend the FDA’s scientific judgment and protect Americans’ access to safe and effective reproductive care.”

The request will first go to Justice Samuel Alito, who is assigned to handle emergency applications from the 5th Circuit. He could act on the application alone or refer it to the full court for consideration.

Given that the rollback goes into effect in less than 48 hours, DOJ could initially ask the justices for an administrative stay, which would bump the timing by a few days until the high court can consider the administration’s request. 

DOJ’s request is likely to then ask the justices to pause Kacsmaryk’s ruling until the 5th Circuit can hand down its ruling in the government’s appeal.

It marks one of the first abortion disputes at the high court since the justices overturned Roe v. Wade last summer.

Unlike that case, which was handled under the Supreme Court’s normal merits docket that involves a months-long process of briefing and oral argument, the DOJ’s request would be placed on the court’s shadow docket.

The high court typically acts on requests on the shadow docket in a matter of days, often without explanation or a public vote count.

“We are going to continue to fight in the courts, we believe the law is on our side, and we will prevail,” White House press secretary Karine Jean-Pierre told reporters early Thursday during President Biden’s visit to Dublin.

Updated at 12:22 p.m.

Previous Post

Top Democrats ask health insurers for response to ObamaCare preventive care ruling

Next Post

Harris: Lawsuit to block mifepristone ‘next step to nationwide abortion ban’

Next Post
Harris: Lawsuit to block mifepristone ‘next step to nationwide abortion ban’

Harris: Lawsuit to block mifepristone 'next step to nationwide abortion ban'

  • Trending
  • Comments
  • Latest
Americans die younger in states with conservative policies: study

Americans die younger in states with conservative policies: study

October 27, 2022
Those at risk for severe COVID-19 often least likely to get monoclonal antibodies

Those at risk for severe COVID-19 often least likely to get monoclonal antibodies

April 26, 2022
Biden says US has offered vaccines to North Korea but got no response

Biden says US has offered vaccines to North Korea but got no response

May 21, 2022
Medicaid cuts could define midterms

Medicaid cuts could define midterms

July 7, 2025
FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

0
Health Care — Draft Supreme Court opinion sets off uproar

Health Care — Draft Supreme Court opinion sets off uproar

0
UN calls reproductive rights ‘foundation’ of equality for women and girls

UN calls reproductive rights ‘foundation’ of equality for women and girls

0
57 percent in new poll want Supreme Court to support abortion rights

57 percent in new poll want Supreme Court to support abortion rights

0
FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

March 10, 2026
Hims & Hers to partner with Novo Nordisk and stop selling compounded GLP-1s

Hims & Hers to partner with Novo Nordisk and stop selling compounded GLP-1s

March 9, 2026
RFK Jr. losing battle to boost trust in public health agencies

RFK Jr. losing battle to boost trust in public health agencies

March 9, 2026
Childhood obesity at a record high as MAHA presses for changes to kids’ diets

Childhood obesity at a record high as MAHA presses for changes to kids’ diets

March 8, 2026

Recent News

FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

March 10, 2026
Hims & Hers to partner with Novo Nordisk and stop selling compounded GLP-1s

Hims & Hers to partner with Novo Nordisk and stop selling compounded GLP-1s

March 9, 2026
RFK Jr. losing battle to boost trust in public health agencies

RFK Jr. losing battle to boost trust in public health agencies

March 9, 2026
Childhood obesity at a record high as MAHA presses for changes to kids’ diets

Childhood obesity at a record high as MAHA presses for changes to kids’ diets

March 8, 2026
Enter Your Information Below To Receive Free Health and Beauty Tips and Ideas





    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2026 wholesomearea.com | All Rights Reserved

    No Result
    View All Result
    • Health Care
    • Health News
    • Healthy Advices
    • Well Being

    Copyright © 2026 wholesomearea.com | All Rights Reserved